ALSP

ALSP Inc. is a privately held company based in San Diego, California, developing small molecule drugs for treating neurodegenerative diseases, initially focused on traumatic brain injury (TBI) and Alzheimer's disease (AD). Our approach is to identify key enzymes in the brain, called neuroproteases, which produce biologically active peptides that are thought to cause the condition. Those enzymes become targets for screening compounds that inhibit the neuroproteases and thereby reduce production of the harmful peptides.